We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
About the Freedom of Information (FOI) disclosure log
The Department of Health and Aged Care, of which the TGA is a part, is required by section 11C of the Freedom of Information Act 1982 (the FOI Act) to disclose access decisions through a disclosure log on its website. The disclosure log provides access to information which has been released in response to an FOI request. However, personal information and information about the business, commercial, financial or professional affairs of a person is deleted from the documents if publication of that information would be unreasonable.
The documents released by the TGA under section 11C of the FOI Act have been made available on this site in Portable Document Format (PDF). They are available for downloading and printing. If you require access to the documents in an alternative format please contact the FOI Coordinator by emailing tga.foi@health.gov.au or calling the TGA on 1800 020 653 or 02 6289 4630.
For information on what’s involved when you request information from us and what's covered under the FOI Act, go to Freedom of information.
For documents released under the FOI Act by the Australian Government Department of Health and Aged Care, please visit the Department of Health's FOI disclosure log.
Our Freedom of Information (FOI) disclosure log
| Date of release | FOI number | Documents |
|---|---|---|
| 14 November 2025 | 26-2078 | Report listing overseas medicine manufacturing sites located in the People’s Republic of China that have been included in an active TGA GMP clearance for sterile injectable (parenteral) vials/bags, covering the manufacture of human medicines. |
| 31 October 2025 | 26-2256 | Data relating to the supply of vaping products via the Special Access Scheme Category C from 1 October 2024 – 30 September 2025. |
| 31 October 2025 | 26-2274 | Data relating to Special Access Scheme and Authorised Prescriber approvals for Levosimendan for infusion for the period 1 January 2024 to 31 July 2025. |
| 22 October 2025 | 26-2239 | Data relating to Special Access Scheme applications for Metyrapone, Ketoconazole, Tocilizumab, Rituximab and Unituxin for the period 2018 to 29 September 2025. |
| 14 October 2025 | 26-1958 | Documents relating to Iverjohn-12 and Ivervid-12 branded tablets. |
| 13 October 2025 | 26-1870 | Liber Pharmaceuticals involvement in 2024 vaping reforms. |
| 7 October 2025 | 26-1990 | Approved carton and vial label artwork for Vidaza Powder for Injection, 100 mg. |
| 5 October 2025 | 26-2278 | Data on the number of units of unregistered medicinal cannabis products supplied for the period 1 January 2025 to 30 June 2025. |
| 30 September 2025 | 26-2142 | Data on the number of units of unregistered medicinal cannabis products supplied for the period 1 January 2025 to 30 June 2025. |
| 30 September 2025 | 26-2122 | Minutes of the 161st meeting of the Pharmaceutical Sub Committee of the Advisory Committee on Prescription Medicines on 24th March 2015 regarding the matter of preservatives in single use injections. |
| 30 September 2025 | 26-1879 | Copies of earliest iteration of product packaging for various over-the-counter medications. |
| 29 September 2025 | 26-2100 | Data relating to Schedule 3 Special Access Scheme (SAS C) pharmacist notifications to TGA of supply of vaping products from 1 October 2024 – 31 August 2025. |
| 29 September 2025 | 26-2102 | Data relating to medicinal cannabis SAS-B applications for the period November 2021 to 31 July 2025. |
| 29 September 2025 | 26-1874 | Copies of earliest iteration of product packaging for various over-the-counter medications. |
| 25 September 2025 | 25-0158 | TGA signal notification assessments, signal investigation and signal evaluation documents for the potential safety signals of COVID-19 vaccines for menstrual cycle irregularities/disorders. |
| 23 September 2025 | 25-0216 | Documents relating to the Complementary and OTC Medicines Regulatory & Technical Forum (ComTech). |
| 11 September 2025 | 25-0214 | Device Incident Reports (DIR) and documents relating to Stryker Hip Stem (ARTG 145594) and Acetabular Shell (ARTG 152396). |
| 9 September 2025 | 25-0197 | Carton design, label design, product information and consumer medicine information relating to Depo-Provera (ARTG 12300, 12279 and 401610); and Depo‐Ralovera (ARTG 44464). |
| 8 September 2025 | 26-1867 | ARTG Certificates and Registration entries for Nitrostat (AUST R 438851 and 438870) and Anginine (AUST R 11086 and 227783). |
| 1 September 2025 | 26-1963 | Adverse event data for COVID-19 vaccines from 21 December 2020 to 31 July 2025. |
| 29 August 2025 | 26-1936 | Laboratory reports for Iverheal-12 |
| 29 August 2025 | 26-1978 | Schedule 3 Special Access Scheme (SAS C) pharmacist notifications to TGA of supply of vaping products from 1 October 2024 – 31 July 2025. |
| 27 August 2025 | 26-1889 | Documents relating to the cancellation of Bioglan Astragalus (ARTG ID 289150 from the Australian Register of Therapeutic Goods. |
| 26 August 2025 | 25-0211 | GMP Inspection reports for GMP Pharmaceuticals Pty Ltd as the licensed manufacturer. |
| 21 August 2025 | 25-0232 | TGA assessment report related to evaluation of ZO-RUB HP capsaicin 0.075% w/w cream tube (AUST R 198783). |
| 18 August 2025 | 25-0223 | Documentation relating to adverse reactions or potential adverse reactions for therapeutic sunscreens under the brand name Ultra Violette. |
| 15 August 2025 | 25-0206 | Documents relating to ARTG 295158 - Intense pulsed light skin surface treatment system. |
| 15 August 2025 | 25-0217 | Correspondence relating to the processing of FOI 25-0171 between the FOI requester and the TGA. |
| 7 August 2025 | 26-1890 | Adverse event notifications made to the TGA, and associated correspondence, for all unapproved medicinal cannabis products. |
| 6 August 2025 | 25-0199 | Documents related to internal audits conducted by the TGA’s Pharmaceutical Inspectorate. |
| 1 August 2025 | 25-0204 | Request for application, including any form of supporting documentation for ARTG 488139 – Dr Nature Immunity & Lung Tablet. |
| 30 July 2025 | 26-1888 | Special Access Scheme data for Cefiderocol for the period 1 January 2020 to 30 June 2025. |
| 28 July 2025 | 2565 | Toxicity studies of COVID-19 vaccines. |
| 24 July 2025 | 25-0233 | Special Access Scheme and Authorised Prescriber data for MDMA/psilocybin for the period 1 July 2023 to 30 June 2025. |
| 24 July 2025 | 26-1861 | Special Access Scheme (SAS) notifications of vaping supply from 1 October 2024 to 30 June 2025. |
| 22 July 2025 | 25-0165 | Documents relating to the reintroduction of Zantac in the Australian market. |
| 21 July 2025 | 25-0040 | Documents relating to menstrual problems following COVID-19 vaccination. |
| 14 July 2025 | 25-0222 | Spreadsheet containing time-to-death (TTD) data, attenuated to include only the TTD data for adverse event reports where the only coded MedDRA term is ‘adverse event following immunisation’. |
| 14 July 2025 | 2255 | Documents relating to Covid-19 otherwise known as Coronavirus Disease 2019 and SARS-CoV-2. |
| 7 July 2025 | 25-0417 | Documents relating to Boston Scientific Pty Ltd pacemakers. |
| 1 July 2024 to 30 June 2025 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2024 - Jun 2025 | |
| 1 Jul 2023 to 30 Jun 2024 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2023 - Jun 2024 | |
| 1 Jul 2022 to 30 Jun 2023 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2022 to Jun 2023 | |
| 1 Jul 2021 to 30 Jun 2022 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2021 to Jun 2022 | |
| 1 Jul 2020 to 30 Jun 2021 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2020 to Jun 2021 | |
| 1 Jul 2019 to 30 Jun 2020 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2019 to Jun 2020 | |
| 1 Jul 2018 to 30 Jun 2019 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2018 to Jun 2019 | |
| 1 Jul 2017 to 30 Jun 2018 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2017 to Jun 2018 | |
| 1 Jul 2016 to 30 Jun 2017 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2016 to Jun 2017 | |
| 1 Jul 2015 to 30 Jun 2016 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2015 to Jun 2016 | |
| 1 Jul 2014 to 30 Jun 2015 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2014 to Jun 2015 | |
| 1 Jul 2013 to 30 Jun 2014 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2013 to Jun 2014 | |
| 1 Jul 2012 to 30 Jun 2013 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2012 to Jun 2013 | |
| 1 Jul 2011 to 30 Jun 2012 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2011 to Jun 2012 | |